Speaker
Steffen S. Docken
(Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia)
Primary authors
Steffen S. Docken
(Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia)
Agatha Macairan
(AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA)
Benjamin Varco-Merth
(Vaccine and Gene Therapy Institute, Oregon Health and Science University, Oregon, USA)
Christine M. Fennessey
(AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA)
Timothy Schlub
(Sydney School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia)
Deborah Cromer
(Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia)
Louis J. Picker
(Vaccine and Gene Therapy Institute, Oregon Health and Science University, Oregon, USA)
Afam A. Okoye
(Vaccine and Gene Therapy Institute, Oregon Health and Science University, Oregon, USA)
Claire Deleage
(AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA)
Taina T. Immonen
(AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA)
Brandon F. Keele
(AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA)
Miles P. Davenport
(Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia)
